LabStyle Innovations Corp Stock Nasdaq
Stocks
US50544T3023
Medical Equipment, Supplies & Distribution
| Market Cap | 50.67M 44.18M 40.92M 38.31M 71.84M 4.78B 72.28M 485M 188M 2.35B 190M 186M 8.17B | P/E 2026 * |
-1.75x | P/E 2027 * | -3.57x |
|---|---|---|---|---|---|
| Enterprise Value | 50.67M 44.18M 40.92M 38.31M 71.84M 4.78B 72.28M 485M 188M 2.35B 190M 186M 8.17B | EV / Sales 2026 * |
1.94x | EV / Sales 2027 * | 1.33x |
| Free-Float |
78.92% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: LabStyle Innovations Corp
| 1 day | -1.13% |
| Manager | Title | Age | Since |
|---|---|---|---|
Dov Oppenheim
PRN | Corporate Officer/Principal | - | 11/08/2011 |
Erez Raphael
CEO | Chief Executive Officer | 52 | 09/08/2013 |
Sean Schnapp
DFI | Director of Finance/CFO | - | 01/01/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Erez Raphael
CHM | Chairman | 52 | 23/11/2014 |
Dennis McGrath
BRD | Director/Board Member | 69 | 12/11/2013 |
Hila Karah
BRD | Director/Board Member | 57 | 23/11/2014 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.13% | -6.05% | - | - | 50.67M | |
| -0.10% | +0.26% | -33.52% | -16.79% | 154B | |
| +1.54% | -1.07% | -8.11% | -10.17% | 102B | |
| +0.07% | +2.25% | +60.29% | +60.19% | 56.51B | |
| -1.90% | -3.49% | -7.43% | +46.28% | 52.89B | |
| +1.67% | -1.55% | -14.51% | -44.04% | 39.67B | |
| -1.32% | -1.83% | - | - | 30.39B | |
| +1.74% | -3.85% | -9.41% | -43.32% | 27.96B | |
| +1.35% | -0.26% | +51.96% | -11.10% | 23.17B | |
| +1.15% | +0.56% | -15.91% | -3.37% | 20.35B | |
| Average | +0.30% | -1.30% | +2.92% | -2.79% | 56.28B | |
| Weighted average by Cap. | +0.34% | -1.24% | -6.15% | -2.21% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 26.16M 22.81M 21.12M 19.78M 37.09M 2.47B 37.31M 251M 97.12M 1.21B 98.19M 96.09M 4.22B | 38.23M 33.33M 30.87M 28.9M 54.19M 3.61B 54.52M 366M 142M 1.78B 143M 140M 6.16B |
| Net income | -30.32M -26.43M -24.48M -22.92M -42.98M -2.86B -43.24M -290M -113M -1.41B -114M -111M -4.89B | -15.68M -13.67M -12.66M -11.86M -22.23M -1.48B -22.37M -150M -58.23M -728M -58.87M -57.61M -2.53B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
